Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities
Johannes Foßelteder(Medical University of Graz), Andreas Reinisch(Stem Cell Institute), Gabriel Pabst(Research Institute of Molecular Pathology), Karl Kashofer(Medical University of Graz), Armin Zebisch(Medical University of Graz), Slave Trajanoski(Medical University of Graz), Albert Wölfler(Medical University of Graz), Tommaso Sconocchia(Istituto di Farmacologia Traslazionale), Heinz Sill(Medical University of Graz), Lisa Auinger(Medical University of Graz), Angelika Schlacher(Medical University of Graz), Danièl Thomas(Unknown), Claudia Waskow(Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)), Christine Beham‐Schmid(Medical University of Graz), Wolfgang Schöll(Medical University of Graz)
Cited by 20
Related Papers
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
|Nature Medicine|2015|579
Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
|Transfusion|2007|507
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
|Cancer and Metastasis Reviews|2020|334